EX-32.1 8 rlay-ex321_8.htm EX-32.1

Exhibit 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Relay Therapeutics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:

| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 25, 2021 |  | By: | /s/ Sanjiv K. Patel
|  |  | Sanjiv K. Patel
|  |  | President and Chief Executive Officer (Principal Executive Officer)

Date: March 25, 2021 |  | By: | /s/ Thomas Catinazzo
|  |  | Thomas Catinazzo
|  |  | Senior Vice President, Finance (Principal Accounting Officer and Principal Financial Officer)